Literature DB >> 8157449

Glycoconjugate vaccines. What next?

K E Stein.   

Abstract

The principle that infants can be protected from invasive diseases caused by encapsulated organisms has been proved with the introduction of Haemophilus influenzae type b conjugate vaccines. The use of glycoconjugates to implement some of the goals of the Children's Vaccine Initiative requires a clear delineation of the chemical and immunological specifications for optimal vaccines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8157449     DOI: 10.1017/s0266462300014094

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  6 in total

1.  Cognate stimulatory B-cell-T-cell interactions are critical for T-cell help recruited by glycoconjugate vaccines.

Authors:  H K Guttormsen; A H Sharpe; A K Chandraker; A K Brigtsen; M H Sayegh; D L Kasper
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

Review 2.  Substrate and donor specificity of glycosyl transferases.

Authors:  B Ernst; R Oehrlein
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

3.  Immunologic memory induced by a glycoconjugate vaccine in a murine adoptive lymphocyte transfer model.

Authors:  H K Guttormsen; L M Wetzler; R W Finberg; D L Kasper
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

4.  Carbohydrates as potentially versatile core subcarriers for multivalent immunogens.

Authors:  Divya Kushwaha; Peng Xu; Pavol Kováč
Journal:  RSC Adv       Date:  2017-01-24       Impact factor: 3.361

Review 5.  Hib Vaccines: Past, Present, and Future Perspectives.

Authors:  Adi Essam Zarei; Hussein A Almehdar; Elrashdy M Redwan
Journal:  J Immunol Res       Date:  2016-01-20       Impact factor: 4.818

6.  A preliminary study on the application of PspA as a carrier for group A meningococcal polysaccharide.

Authors:  Lichan Wang; Yajun Tan; Chen Wei; Huajie Zhang; Peng Luo; Shumin Zhang; Xiao Ma
Journal:  PLoS One       Date:  2019-07-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.